Search

This policy describes the standards and processes required to support colleagues that are affected by incidents an events at work.

This document clarifies the responsibility of Mersey Care NHS Foundation Trust clinicians and establishes the standards in respect of the management & decontamination of medical devices

To provide information and guidance to Mersey Care NHS Foundation Trust directors. managers and staff on their responsibilities concerning fire safety at work.

The purpose of this policy is to ensure that all linen and laundry is supplied in a good condition and that it has been handled and processed to the highest possible standard, minimising the risk of infection to both Staff and Service Users, contributing to the quality standards and in accordance with National Standards and Guidelines

This document clarifies the responsibility of Mersey Care NHS Foundation Trust clinicians and establishes the standards in respect of the theory and practice of venepuncture

The purpose of the Medical Workforce Acting Down Protocol is to provide guidance for medical staff when unexpected absences occur and alternative cover is required

To ensure that premises are cleaned and maintained to the highest possible standard, minimising the risk of infection and contributing to a visible impression of quality, in accordance with NHS national standards and guidelines.

To provider guidance to staff to enable Mersey Care NHSFT to comply with the new Provider Selection Regime when procuring (or sub-contracting) relevent health care services, in line with relevent legislation and national guidance

The objective of this policy is to describe the framework for managing Clinical Audit and describes:- • The duties of all parties within Mersey Care NHS Foundation Trust • The development of the Clinical Audit Plan • The Clinical Audit Process • The process for monitoring compliance with the standards of the policy

This procedure provides guidance to ensure that valpoate treatment is appropriately and safely used in accordance with regulatory requirements for all female children and women of childbearing potential and males under the age of 55 years. It advises health care professionals of the actions to be taken to educate patients on safe use of valproate and ensure awareness of the potential risk of birth defects and congenital malformations associated with taking valproate in pregnancy.